Ocugen Alternatives & Competitors
12 companies similar to Ocugen — Approaching healthcare innovation with purpose and agility to deliver new breakt...
Retex Pharmaceuticals
Watertown, United States
Ocular Therapeutix, Inc.
Bedford, United States
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune dis...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Track all Ocugen competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Mozart Therapeutics, Inc.
Orchestrating the Immune System
Seattle, United States
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
Umea, Sweden
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Boston, United States
Regeneron
Tarrytown, United States
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
San Diego, United States
About Ocugen
Approaching healthcare innovation with purpose and agility to deliver new breakthroughs for people facing disease.
Development of Gene Therapies, Research and Development, Clinical Trial Management, Patient-Centric Solutions
Patients with Retinal Diseases, Healthcare Providers, Medical Researchers, Investors in Biotech Sector
Gene Therapy, Blindness Diseases, Ophthalmology, Clinical-stage Biopharmaceutical, Modifier Gene Therapy Platform, Inherited Retinal Disorders, COVID-19 Vaccine, Wet Age-related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Therapeutics, Biologics, Rare Diseases, Commercialization
B2B, B2C, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Ocugen and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Ocugen on 9 Jun 2026. The 12 companies listed here were last checked between 13 Mar 2026 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.